redrock tirzepatide Eli Lilly sues companies selling alternative versions of its weight loss drug Tirzepatide for Weight Loss —

During the Biden administration, Congress enacted the Inflation Reduction Act of 2022, which authorized the federal government to negotiate lower drug prices with manufacturers for some drugs covered by Medicare, among other provisions, resulting in an estimated reduction in the federal deficit of $237 billion over 10 years for the drug pricing provisions alone

Hype has quickly built around the drug, leading to shortages and rumors that it's used by celebrities

Clinical trials endorse its efficacy, often resulting in 15% to 20% of body weight loss when paired with lifestyle adjustments

References Muller, T.D., Finan, B., Bloom, S.R., et

Have struggled with traditional weight loss methods like diet and exercise